The Bipartisan Policy Center applauds the Senate HELP Committee for passing the Food and Drug Administration Reauthorization Act of 2017.
The bill provides a $2 billion increase in funding for the National Institutes of Health (NIH) to support important research.
Timely completion and passage of FDA user fee reauthorization legislation is a crucial next step toward helping Americans in need.
The bigger concern is the fact that it takes more than ten years and $2 billion to develop a new drug from a molecule to a medicine.
Congress has four remaining work weeks in Washington to hash out the budget and hopefully finish work on the “21st Century Cures” legislation.
There are only 500 approved treatments for the approximately 10,000 known molecular-based diseases. The urgency of finding the next generation of cures is clear.
House Energy and Commerce Chairman Fred Upton is working to push his much beloved 21st Century Cures bill over the finish line.